Evidence map›Paper›PMID 33038592›Full record

ArticleThe journal of allergy and clinical immunology. In practice2021

Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection.

Doriane Calmes, Sophie Graff, Nathalie Maes, Anne-Noëlle Frix, Marie Thys, Olivier Bonhomme, Julien Berg, Mathieu Debruche, Fanny Gester, Monique Henket and 19 more

Abstract read
In one paragraph

Article in The journal of allergy and clinical immunology. In practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Obesity as an independent risk factor for COVID-19 severity and mortality.The Cochrane database of systematic reviews · 2023
    Pooled it
  5. The impact of comorbid allergic airway disease on the severity and mortality of COVID-19: a systematic review and meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Clinical features in patients with COVID-19 treated with biologics for severe asthma.The journal of allergy and clinical immunology. Global · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Regular Inhaled Corticosteroids Use May Protect Against Severe COVID-19 Outcome in COPD.International journal of chronic obstructive pulmonary disease · 2023
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Doriane CalmesDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Sophie GraffDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Nathalie MaesDepartment of Medico-economics Informations, CHU Sart-Tilman B35, Liege, Belgium.
Anne-Noëlle FrixDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Marie ThysDepartment of Medico-economics Informations, CHU Sart-Tilman B35, Liege, Belgium.
Olivier BonhommeDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Julien BergDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Mathieu DebrucheDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Fanny GesterDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Monique HenketDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Virginie PaulusDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Bernard DuysinxDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Vincent HeinenDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Delphine Nguyen DangDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Astrid PaulusDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Valérie QuaedvliegDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Frederique VaillantDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Hélène Van CauwenbergeDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Michel MalaiseDepartment of Internal Medicine, CHU Sart Tilman B35, Liege, Belgium.
Alisson GilbertEmergency Department, CHU Sart-Tilman B35, Liege, Belgium.
Alexandre GhuysenEmergency Department, CHU Sart-Tilman B35, Liege, Belgium.
Pierre GilletCHU Sart-Tilman B35, Liege, Belgium.
Michel MoutschenDepartment of Infectious Diseases, CHU Sart-Tilman B35, Liege, Belgium.
Benoit MissetIntensive Care Unit, CHU Sart-Tilman B35, Liege, Belgium.
Anne SibilleDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Julien GuiotDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Jean-Louis CorhayDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Renaud LouisDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium.
Florence SchleichDepartment of Respiratory Medicine, CHU Sart-Tilman B35, Liege, Belgium. Electronic address: fschleich@chuliege.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAsthmatics and patients with chronic obstructive pulmonary disease (COPD) have more severe outcomes with viral infections than people without obstructive disease.

objectiveTo evaluate if obstructive diseases are risk factors for intensive care unit (ICU) stay and death due to coronavirus disease 2019 (COVID19).

methodsWe collected data from the electronic medical record from 596 adult patients hospitalized in University Hospital of Liege between March 18 and April 17, 2020, for severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection. We classified patients into 3 groups according to the underlying respiratory disease, present before the COVID19 pandemic.

resultsAmong patients requiring hospitalization for COVID19, asthma and COPD accounted for 9.6% and 7.7%, respectively. The proportions of asthmatics, patients with COPD, and patients without obstructive airway disease hospitalized in the ICU were 17.5%, 19.6%, and 14%, respectively. One-third of patients with COPD died during hospitalization, whereas only 7.0% of asthmatics and 13.6% of patients without airway obstruction died due to SARS-CoV2. The multivariate analysis showed that asthma, COPD, inhaled corticosteroid treatment, and oral corticosteroid treatment were not independent risk factors for ICU admission or death. Male gender (odds ratio [OR]: 1.9; 95% confidence interval [CI]: 1.1-3.2) and obesity (OR: 8.5; 95% CI: 5.1-14.1) were predictors of ICU admission, whereas male gender (OR 1.9; 95% CI: 1.1-3.2), older age (OR: 1.9; 95% CI: 1.6-2.3), cardiopathy (OR: 1.8; 95% CI: 1.1-3.1), and immunosuppressive diseases (OR: 3.6; 95% CI: 1.5-8.4) were independent predictors of death.

conclusionAsthma and COPD are not risk factors for ICU admission and death related to SARS-CoV2 infection.

Indexed as

AsthmaBelgiumComorbidityCOVID-19Critical IllnessFemaleHumansIntensive Care UnitsLength of StayMaleMiddle AgedPulmonary Disease, Chronic ObstructiveRisk FactorsSARS-CoV-2AsthmaCOPDCOVID19DeathICURisk factorsSARS-CoV2Severe asthmaViral infection

Identifiers

PMID33038592
PMCPMC7539890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.